Anti-gonadotrophin releasing hormone vaccine (Aphton/GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-gonadotrophin releasing hormone vaccine (Aphton/GlaxoSmithKline)
Drug Alias NameGnRH immunogenGnRH pharmaccineGonadimmune
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsEstrogen receptors antagonistsProgesterone receptor antagonists +[4] 
TargetsEstrogen receptorsGonadotropin-releasing hormoneProgesterone receptor
Therapy Area/IndicationsEndometriosisProstatic NeoplasmsEndometrial Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAphton Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAphton CorpGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsEndometriosisProstatic NeoplasmsEndometrial Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A